Jintropin® manufacturered by GeneScience Pharmaceuticals now available in Mexico.

Mexico City, Mexico - September 16, 20111 - GeneScience Pharmaceuticals has received marketing approval for Jintropin® [somatropin (rDNA origin) for injection] under the brand name JTPN® Somatropina from the Secretaria De Salud.
By: GeneScience Pharmaceuticals
 
 
Spread the Word
Listed Under

Tags:
Hgh
Jintropin
JTPN Somatropina

Industry:
• Pharmaceutical

Location:
Mexico City - Distrito Federal - Mexico

Sept. 16, 2011 - PRLog -- JTPN ® Somatropina [somatropin (rDNA origin) for injection] is a human growth hormone produced by recombinant DNA technology. JTPN® has 191 amino acid residues and a molecular weight of 22,125 daltons. Its amino acid sequence and structure is identical to the dominant form of human pituitary growth hormone. JTPN® is expressed by a patented E. coli secretion system that has been modified by the addition of the human growth hormone gene.

JTPN ® Somatropina will now be available in pharmacies and hospitals throughout Mexico.  "The quality and affordability of JTPN ® Somatropina will make it a popular product" says Ernesto Gomez manager at a Farmacias Similares drug store in Mexico City.

About GeneScience Pharmaceuticals

GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the largest and most pofitable biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients.

GenSci is headquartered in Changchun, China, with 6 approved products on the market.  GenSci's core product, GenLei® Jintropin™ (rhGH, somatropin for injection) has been the leading brand of rhGH in China with a dominant 70% of the market share. GenSci's profitability has been ranked No. 1 among Chinese biopharmaceutical companies.

# # #

About GeneScience Pharmaceuticals
GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients.
GenSci is headquartered in Changchun, China, with 6 approved products on the market. GenSci's core product, GenLei® Jintropin™ (rhGH, somatropin for injection) has been the leading brand of rhGH in China with a dominant 70% of the market share. GenSci's profitability has been ranked No. 1 among Chinese biopharmaceutical companies.
End
Email:***@jtpn.com.mx Email Verified
Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share